In the heart of the capital city: CSL Behring creates new jobs with project "Protinus"
CSL Behring in Lengnau: Thermo Fisher Scientific and CSL enter strategic partnership
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people's health.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver our promise to save lives and protect the health of people.
Grow with us: CSL Behring offers university graduates an interesting career as a trainee.
News from our Protinus Project
CSL Limited delivered full year net profit of $2,255 billion.
During the "SoFeWo", children from the northern neighborhood of Bern pursue a meaningful leisure activity.
It has already been two years since we, as stadium partner, officially renamed the home of our neighbor BSC Young Boys "Stadi…
For the 1st YB soccer game of the 2022/23 season, CSL Behring is giving away free tickets!
New medications are needed to treat acute respiratory failure. Their development can be fast-tracked by combining efforts in …
CSL Behring and Energie Wasser Bern award the Bern Environmental Research Prize 2022.
Three best Master Students awarded by CSL Behring
Eight of our leaders share the difference between ‘managing’ and ‘leading’.
On 28 February, the rare disease community will once again join together to recognize Rare Disease Day.
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
